INTRODUCTION
The role of the brain melanocortin system in energy balance regulation is acknowledged (7, 13, 18, 33, 44) . This system comprises the proopiomelanocortin (POMC) neurons of the hypothalamic arcuate nucleus (ARC) and the widely distributed melanocortin-4 receptors (MC4R), which are important partners in controlling food intake and energy expenditure. POMC and Mc4r knockout or loss-of-function mutations are associated with severe obesity in laboratory rodents (21) as well as in humans (16) . Consistent with this, the POMC product a melanocyte-stimulating hormone (αMSH) and the αMSH synthetic analog Melanotan II, which represent MC4R/MC3R agonists, suppress food intake and stimulate energy expenditure (14, 22) .
In addition to reducing food intake, MC4R agonism has been reported to increase energy expenditure through stimulating brown adipose tissue (BAT) thermogenesis (6, 15, 39, 41, 42) .
Increases in BAT temperature (39, 41) , BAT sympathetic nervous system (SNS) activity (15) and BAT expression of uncoupling protein 1 (UCP1) and accessory thermogenic genes (43) have all been observed after brain ventricular and parenchymal injections of MC4R agonists. BAT involvement in MC4R-mediated thermogenic effects is also supported by observations obtained in Mc4r knockout or SHU9119 (MC4R antagonist)-treated animals, which exhibit diminished BAT thermogenic capacity/activity (22, 42) . Additionally, the role of the MC4R in controlling BAT thermogenesis is anatomically supported by retrograde viral transneuronal tracing studies, which have demonstrated the strong connection between MC4R mRNA-expressing neurons and the SNS outflow to iBAT (41) .
There is good evidence that the paraventricular hypothalamic (PVH) (41) , ARC (12) , and brainstem (39) are sites of the thermogenic action of MC4R agonists. However, the brain circuits involved in the MC4R-mediated control of BAT thermogenesis remain to be fully unraveled. Several brain regions expressing the MC4R have not been systematically investigated as sites of the MC4R-mediated action on BAT thermogenesis. Among those regions, the preoptic area (POA) is certainly a worthy candidate. The POA represents the second hypothalamic region, next to the PVH, with the highest proportion of neurons connected to BAT (via the SNS) that express the MC4R (41) . Within the POA, MC4R mRNA is widely expressed in the medial preoptic nucleus (MPO) (24) , which is involved in thermoregulatory thermogenesis (30, 31) . The MPO hosts inhibitory neurons that modulate the activity of the excitatory neurons of the dorsomedial hypothalamic nucleus (DMH) that control interscapular BAT (iBAT) activity via the raphe pallidus (RPa) (27, 34) . The observation that inhibition of neurons found in the rostral RPa blocks the thermogenic effect of ventricular injection of MTII (15) supports the involvement of a MPO-DMH-RPa-SNS circuit in the MC4R-mediated effect on iBAT activity.
The objective of the present study was to verify whether the MPO could be a site where MTII could stimulate brown fat thermogenesis and metabolism with the complicity of the DMH.
The effects of the MPO infusion of MTII on iBAT temperature as well as on iBAT 14 Cbromopalmitate and 3 H-deoxyglucose uptake were assessed in male Wistar rats with or without DMH lesions. The uptake of the radiolabelled energy substrate was also measured in inguinal white adipose tissue (iWAT), liver and heart. Furthermore, iBAT and iWAT expression of thermogenic and metabolic genes was measured in animals killed one hour following MTII with or without DMH lesions. iWAT was studied since it represents a WAT depot where brown adipocytes can develop under appropriate adrenergic stimulation (3) and since it is, similar to iBAT, connected to the MPO-MC4R neurons via the SNS (40) . 
MATERIALS AND METHODS

Animals
Drugs
The MC4R/MC3R agonist MTII (Phoenix Pharmaceutical Inc, Burlingame CA, USA) was dissolved in aCSF and administered at dose of 200 ng in a volume 200 nl (100 nl in each side of the MPO). Kainic acid (1 mg/ml, Sigma) was dissolved in sterile saline and adjusted to pH 7.2-7.4 by using 0.1 M NaOH. The dose of MTII (22) and kainic acid (26) were selected from previous studies (26) .
Brain preparation
At time of killing, rats were anesthetized with 1.5 ml mixture containing 20 mg/ml ketamine and 2.5 mg/ml xylazine and intracardially perfused with 50 ml of ice-cold isotonic saline followed by 500 ml of paraformaldehyde (4%) solution. Brains were removed and kept in paraformaldehyde for an additional period of 7 days. They were then transferred overnight to a solution containing paraformaldehyde (4%) and sucrose (10%) and sliced from the olfactory bulb to the brainstem using a sliding microtome (Histoslide 2000, Reichert-Jung, Heidelberg, Germany). Thirty-µm thick sections of the PVH were collected and stored at −30°C in a cold cryoprotecting solution containing sodium phosphate buffer (50-mM), ethylene glycol (30%), and glycerol (20%). The sections were examined for the cannula placement or underwent a Nissl staining to verify the lesion.
MPO MTII infusions
Rats were chronically implanted with bilateral (1.0 mm between tubes) guide-cannulas (26-gauge -Plastics One, Roanoke, VA, USA), aimed at the MPO, using the following coordinates relative to bregma: 0.5 mm on each side of the midline, 0.6 mm posterior and 6.5 mm ventral to the brain surface (37) . The cannula was fixed in place using dental cement (Lang Dental Manufacturing co., Inc, Wheeling, IL, USA) and anchoring screws. Sterile obturators were inserted into the guide-cannulas to avoid blockage. The placement of the cannulas was further confirmed under microscope the end of the study and the injection sited were estimated. were subjected to the MTII infusions 10 days after the injections of kainic acid.
iBAT thermogenesis and iBAT and iWAT energy substrate uptakes Four (4) groups of rats with or without DMH lesions were used to assess the effects of aCSF or MPO-infused MTII on iBAT thermogenesis. iBAT temperature was assessed under isoflurane anesthesia, using a copper-constantan thermocouple (Physitemp Instruments, Inc.
Clifton, NJ, USA) inserted into the right iBAT pad. During the measurement, core temperature was monitored with a second thermocouple inserted 6 cm into the rectum (20) . Skin temperature was also assessed with a third copper-constantan thermocouple placed on the left-rear leg. Core and skin measurements were performed before the MPO infusions in order to avoid body temperature variations. Measurement of CO 2 exhaled was assessed using a CO 2 analyser (model S-3A, Applied Electrochemistry Incorporated, Sunnyvale, CA, USA). CO 2 exhaled was used to gauge whole-body thermogenesis. VO 2 could not be measured for technical reasons inherent to the use of the isoflurane mask during the MPO infusions of MTII.
In addition to the iBAT temperature and CO 2 exhaled measurements, we also measured iBAT, iWAT, liver and heart 14 C-bromopalmitate ([1-
14 C-bromopalmitate was used to assess non-esterified fatty acid (NEFA) uptake (28, 29) and to estimate lipid oxidation (10, 29, 36) and esterification (29) , whereas 3 H-deoxyglucose was used to trace glucose uptake (17 Table 1 .
The mRNA transcript levels were measured in duplicates through chemical detection of the PCR products with SYBR® Green JumpStart™ Taq ReadyMix™ (#S5193, Sigma Aldrich, USA) using a Rotor Gene 3000 system (Montreal Biotech, Montreal, QC, Canada). At the end of each run, melt curve analyses were performed. A few samples, representative of each experimental group, were run on agarose gel and sequenced to ensure the specificity of the amplification. Slope of standard curve was used to evaluate PCR efficiency; an efficiency between 90 and 100% was considered acceptable. Results were expressed as the ratio of the expression of the target gene to that of the housekeeping gene acidic ribosomal phosphoprotein (Arbp), which was selected as no significant variation in its expression was observed after our treatment.
Statistical analyses
Values obtained from rats with improper placement of cannula were excluded from the statistical analyses. Results are expressed as means ± SEMs. Comparisons were done on normally distributed data using two-way ANOVAs followed by Bonferroni post hoc tests to assess the differences between various conditions with Graph pad Prism Software version 6.0 for Mac (San Diego, CA, USA). We considered the following comparisons: Differences were considered statistically significant when P values were less than 0.05.
RESULTS
MTII infusion in the MPO led to an increase (above aCSF) in iBAT temperature, which was abolished by DMH lesions (Figure 2, A-B) . The infusion of MTII also produced an elevation in exhaled CO 2 ( Figure 2, C-D) , which did not reach statistical significance in rats with DMH lesions. The correlation between iBAT temperature elevation and whole body exhaled CO 2 ( Figure 2 , E) proved to be highly significant (r = 0.79, P < 0.001).
Together with measuring iBAT thermogenesis and exhaled CO 2 , we also measured 14 Cbromopalmitate and 3 H-deoxyglucose uptakes in iBAT, iWAT, liver and heart ( Figure 3 ). MPO infusion of MTII led to an increase (above aCSF) in 14 C-bromopalmitate uptake in iBAT, which was prevented by DMH lesions (Figure 3, A) . However, we did not observe any increase in iBAT 3 H-deoxyglucose uptake following MTII (Figure 3, B) , revealing NEFA uptake as a better predictor of iBAT thermogenesis than glucose uptake in the context of the present study.
Correlation analyses, which showed a significant Pearson's r (0.63, P < 0.001) solely between iBAT temperature elevation and 14 C-bromopalmitate uptake ( Figure 3 , C-D), support this deduction. MTII infusion in MPO increased (above aCSF) 14 C-bromopalmitate and 3 Hdeoxyglucose uptakes in iWAT ( Figure 3 , E-F). The effect was however statistically significant (P < 0.05) only for the 14 C-bromopalmitate uptake. MPO infusion of MTII also stimulated liver 14 C-bromopalmitate uptake, which was prevented by DMH lesions (Figure 3, G) . MTII and DMH lesions did not influence liver 3 H-deoxyglucose uptake (Figure 3, H) . Finally, MTII did not increase heart 14 C-bromopalmitate uptake (Figure 3, I ), whereas DMH lesions significantly (P < 0.05) reduced heart 3 H-deoxyglucose uptake, regardless of whether aCSF or MTII was injected in the MPO (Figure 3, H) .
The effects of MTII and DMH lesions on the expression of genes involved in iBAT thermogenesis and metabolism are illustrated in figure 4A . We observed that MTII increased expression of genes involved in lipogenesis (Fas and Dgat2), lipolysis (Hsl) and thermogenesis (Pgc1α and Dio2) in rats with sham lesions. The effects of MTII were however abolished following DMH lesions. As revealed by the correlations presented in Figure 4 , B-C, 14 Cbromopalmitate uptake in iBAT correlated with the expression of Hsl (r = 0.62, P < 0.001), which is implicated in lipolysis, and Dgat2 (r = 0.51, P < 0.01), which is implicated in the synthesis of TG. Figure 4 , D illustrates the effects of the various experimental treatments on the iWAT expression of the genes reported for iBAT in Figure 4 , A. In animals with sham lesions, MTII did not lead to any increase in gene expression. In fact, it reduced Glut4 and Gpat3
expressions. However, in rats with DMH lesions, MTII induced Glut4, Gpat3, Dgat1, Dgat2, Hsl, Atgl and Cpt1 β. As illustrated in Figure 4 , E-F, the mRNA expression of Fas, which is implicated in the synthesis of TG, correlated with 14 C-bromopalmitate (r = 0.46, P = 0.02) and 3 H-deoxyglucose (r = 0.59, P < 0.01) uptakes in iWAT. Table 2 presents the differences (∆) between post-and pre-infusion levels of circulating NEFA, TG, and insulin. Rats with DMH lesions showed a ∆ insulin that was significantly lower than that of aCSF animals with sham lesions. Finally, the averaged weight of rats with DMH lesions at the time of MTII infusion was significantly lower (P < 0.05) than that of animals with sham lesions (331.9 ± 3.9 vs 347.8 ± 4.2). Such an effect had been reporter before (4) .
DISCUSSION
The present results point to the MPO as a site of the thermogenic and metabolic actions of MTII, the synthetic analog of α-MSH and a MC4R/MC3R agonist. The MPO injection of MTII led to an increase in iBAT temperature, which was accompanied by increases in iBAT 14 (30) . The POA has also been reported to be the site of the thermogenic action of corticotropin-releasing factor (8, 11) and prostaglandin E2 (2, 27), which seemingly act by releasing the inhibitory effect of POA GABA neurons on the DMH to stimulate the RPa neurons governing the SNS outflow to iBAT (8, 30) . The DMH neurons are likely to be glutamatergic excitatory neurons (32) . Within the POA, both the MC4R and MC3R
are expressed in relative abundance in the MPO (33) . However, the MC4R is most probably the melanocortin receptor mediating the thermogenic effect of MTII since it is expressed in neurons that are polysynaptically connected to iBAT (41) and iWAT (40) 14 C-bromopalmitate uptake also significantly correlated with iBAT Hsl and Dgat2 mRNA expression further indicating that 14 C-bromopalmitate uptake can be used to predict lipid oxidation (10, 29, 36) and esterification (29) . Noteworthily, Hsl (lipolysis) and Dgat2
(lipogenesis) were among those genes, which also included Fatp1 (fatty acid uptake), Fas (de novo lipogenesis) and Pgc1α and Dio2 (thermogenesis), whose expression underwent a DMHdependent stimulating effect of MTII. We did not observe any induction of Ucp1 following MTII, likely due to the short time period (one hour) elapsing between the MTII treatment and the killing of the rats.
We also observed DMH-dependent metabolic effects of the MPO infusion of MTII in tissues other than iBAT. Indeed, MPO infusion of MTII increased 14 C-bromopalmitate uptake in the liver and iWAT and DMH lesions blunted those effects. Such findings further support the extensive role for the MPO melanocortin receptors and POA/DMH duet in energy metabolism (30, 38) . Given the recognition of iWAT as a WAT depot capable of developing brown adipocytes (beige depot) (3) and the neuroanatomical link between iWAT and the POA via the SNS (40), we choose to examine the same panel of genes in this fat depot as the one we scrutinized in iBAT. The stimulating effects of MTII were however only seen in iWAT of rats with DMH lesions. Indeed, in those rats, MTII induced genes involved in the glucose transport (Glut4), lipogenesis (Gpat3, Dgat1 and Dgat2), lipolysis (Hsl, Atgl) and thermogenesis/metabolism (Cpt1β). The different effects seen in iBAT and iWAT cannot be easily explained. Nonetheless, these findings demonstrate the importance of the DMH in modulating and potentially fine-tuning energy homeostasis. DMH comprises excitatory glutamatergic neurons that were reported to be key players in the control of SNS-mediated iBAT thermogenesis (31, 32, 35) . It seems reasonable to assume that those glutamatergic neurons were affected by kainic acid (1, 4) , which prevented the temperature rise in iBAT induced by the MPO infusion of MTII. On the other hand, the increased expression of genes such as Hsl, Atgl and Cpt1β, which we saw in iWAT after MTII only in rats with damaged DMH, suggests an enhanced iWAT metabolic activity, reminiscent of the effects seen after DMH NPY knockdown (5) . Knockdown of DMH NPY has indeed been reported to stimulate metabolism and the browning of iWAT (due to the development of brown adipocytes) (5). The DMH neurons can produce NPY in neurons that also expressed CART (25) and enhanced expression of NPY in the DMH has been associated with excess fat deposition (45), high fat feeding (25) and lactation (9) .
The possibility that the NPY-expressing neurons could have been damaged by kainic acid cannot be excluded. Further studies are however needed to verify this possibility and further clarify the complex interplay between the POA and DMH in iWAT metabolism.
In conclusion, the present results revealed the MPO as a site of the thermogenic and 
